Quick Answer
Autonomix Medical, Inc. reported Net Income of -$11.41 million for fiscal year 2025.
Autonomix Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | -$11.41M +26.0% |
-$15.43M -675.2% |
-$1.99M | — |
| Total Assets | $9.81M +4.2% |
$9.41M +987.5% |
$865.0K | — |
| Cash and Equivalents | $9.14M +6.1% |
$8.61M +895.1% |
$865.0K | — |
| Stockholders Equity | $8.10M +6.2% |
$7.63M +1084.5% |
$644.0K -67.1% |
$1.96M |
| R&D Expense | $4.72M +112.4% |
$2.23M +198.7% |
$745.0K | — |
| Operating Income | -$11.59M +3.7% |
-$12.03M -504.5% |
-$1.99M | — |
| Shares Outstanding | 2.50M +164.9% |
942,575 -92.4% |
12.34M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | December 31, 2025 | -$3.26M | -20.2% | +56.2% |
| Diluted EPS | December 31, 2023 | -$0.23 | -360.0% | -360.0% |
| Total Assets | December 31, 2025 | $10.21M | -14.6% | +28.7% |
| Cash and Equivalents | December 31, 2025 | $9.93M | -16.0% | +32.9% |
| Long-Term Debt | December 31, 2023 | $1.46M | — | — |
| Stockholders Equity | December 31, 2025 | $8.56M | -11.8% | +32.8% |
| R&D Expense | December 31, 2025 | $1.72M | +65.1% | -27.2% |
| Operating Income | December 31, 2025 | -$3.34M | -21.7% | +55.6% |
| Shares Outstanding | December 31, 2025 | 11.41M | +363.2% | +84.2% |
- Autonomix Medical, Inc. reported Net Income of -$11.41 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +26.0% in Net Income compared to the prior fiscal year.
- Autonomix Medical, Inc. reported Total Assets of $9.81 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +4.2% in Total Assets compared to the prior fiscal year.
- Autonomix Medical, Inc. reported Cash and Equivalents of $9.14 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +6.1% in Cash and Equivalents compared to the prior fiscal year.
- Autonomix Medical, Inc. reported Stockholders Equity of $8.10 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +6.2% in Stockholders Equity compared to the prior fiscal year.
- Autonomix Medical, Inc. reported R&D Expense of $4.72 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +112.4% in R&D Expense compared to the prior fiscal year.
- Autonomix Medical, Inc. reported Operating Income of -$11.59 million for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +3.7% in Operating Income compared to the prior fiscal year.
- Autonomix Medical, Inc. reported Shares Outstanding of 2.50 million shares for fiscal year 2025.
- Autonomix Medical, Inc. showed an increase of +164.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: